ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

TELA TELA Bio Inc

4.63
0.00 (0.00%)
プレマーケット
最終更新日: 22:03:46
15分遅延
名称 銘柄コード 市場 種別
TELA Bio Inc TELA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 4.63 22:03:46
始値 安値 高値 終値 前日終値
4.63
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2520:00GLOBETELA Bio to Announce First Quarter 2024 Financial Results
2024/4/1520:00GLOBETELA Bio Announces U.S. Commercial Launch of..
2024/4/0820:00GLOBETELA Bio Welcomes Acclaimed Surgeon as Vice President of..
2024/3/2205:05GLOBETELA Bio Achieves Record Fourth Quarter and Full Year 2023..
2024/3/2120:00GLOBETELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the..
2024/3/2020:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
2024/2/2921:00GLOBETELA Bio to Announce Fourth Quarter and Full Year 2023..
2024/2/2806:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2406:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2406:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
2024/2/1706:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1706:05EDGAR2Form 3/A - Initial statement of beneficial ownership of..
2024/2/1507:23EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1420:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/2006:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
2023/12/1606:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
2023/12/0806:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0521:00GLOBETELA Bio to Take Part in Connecting the Dots
2023/11/1621:00GLOBETELA Bio to Participate in Piper Sandler’s 35th Annual..
2023/11/1510:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1406:44EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1406:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1106:05GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
2023/11/1006:05GLOBETELA Bio Reports Third Quarter 2023 Financial Results
2023/10/2620:00GLOBETELA Bio to Announce Third Quarter 2023 Financial Results
2023/10/2105:06EDGAR2Form 8-K - Current report
2023/10/0700:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/9/2905:05EDGAR2Form 8-K - Current report
2023/9/1905:05GLOBETELA Bio to Participate in the Gilmartin Group Emerging..
2023/8/1620:15EDGAR2Form 8-K - Current report
2023/8/1620:00GLOBETELA Bio Announces U.S. Commercial Launch of OviTex® PRS..
2023/8/1105:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1005:05EDGAR2Form 8-K - Current report
2023/8/1005:03GLOBETELA Bio Reports Second Quarter 2023 Financial Results
2023/8/0505:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0505:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/0505:02GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..
2023/7/2620:00GLOBETELA Bio to Announce Second Quarter 2023 Financial Results..
2023/6/1520:00GLOBENew Survey Finds Strong Consumer Preference for More Natural..
2023/5/2520:00GLOBETELA Bio to Participate in the Jefferies Global Healthcare..
2023/5/1920:00GLOBETELA Bio Invests in Surgeon Training and Education with..
2023/5/1205:02GLOBETELA Bio Reports First Quarter 2023 Financial Results
2023/5/0920:00GLOBETELA Bio Supports Diversity and Inclusion at International..
2023/5/0905:30GLOBETELA Bio Announces Inducement Grants Under Nasdaq Listing..

最近閲覧した銘柄

Delayed Upgrade Clock